101 related articles for article (PubMed ID: 1359081)
1. Sulphasalazine fails to prevent development of mucosal ulceration and 5-lipoxygenase activity in guinea-pigs with chronic inflammatory bowel disease induced by combined bacterial immunization and oral carrageenin.
Oestreicher P; Nielsen ST; Rainsford KD
J Pharm Pharmacol; 1992 Jun; 44(6):528-31. PubMed ID: 1359081
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease induced by combined bacterial immunization and oral carrageenan in guinea pigs. Model development, histopathology, and effects of sulfasalazine.
Oestreicher P; Nielsen ST; Rainsford KD
Dig Dis Sci; 1991 Apr; 36(4):461-70. PubMed ID: 1672517
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus.
Onderdonk AB; Cisneros RL; Bronson RT
Infect Immun; 1983 Nov; 42(2):783-8. PubMed ID: 6642651
[TBL] [Abstract][Full Text] [Related]
4. Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases.
Jupp J; Hillier K; Elliott DH; Fine DR; Bateman AC; Johnson PA; Cazaly AM; Penrose JF; Sampson AP
Inflamm Bowel Dis; 2007 May; 13(5):537-46. PubMed ID: 17230539
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-lipoxygenase inhibition on events associated with inflammatory bowel disease in rats.
Singh VP; Patil CS; Kulkarni SK
Indian J Exp Biol; 2004 Jul; 42(7):667-73. PubMed ID: 15339030
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of immune enhancement of experimental ulcerative colitis.
Onderdonk AB; Steeves RM; Cisneros RL; Bronson RT
Infect Immun; 1984 Oct; 46(1):64-7. PubMed ID: 6480115
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice.
Rainsford KD
J Pharm Pharmacol; 1999 Mar; 51(3):331-9. PubMed ID: 10344635
[TBL] [Abstract][Full Text] [Related]
8. 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Rask-Madsen J; Bukhave K; Laursen LS; Lauritsen K
Agents Actions; 1992; Spec No():C37-46. PubMed ID: 1359745
[TBL] [Abstract][Full Text] [Related]
9. Ulceration of the colon in guinea-pigs fed carrageenin.
Watt J; Marcus R
Proc Nutr Soc; 1970 May; 29(1):Suppl:4A. PubMed ID: 5482557
[No Abstract] [Full Text] [Related]
10. 5-Hydroxyeicosatetraenoic acid and leukotriene D4 increase intestinal epithelial paracellular permeability.
Rodríguez-Lagunas MJ; Storniolo CE; Ferrer R; Moreno JJ
Int J Biochem Cell Biol; 2013 Jul; 45(7):1318-26. PubMed ID: 23583294
[TBL] [Abstract][Full Text] [Related]
11. 5-Lipoxygenase inhibitory and antihistamine activities of linetastine.
Shizawa T; Ohmori S; Maeda K; Sakata K; Ishii T; Kamitani T
Arzneimittelforschung; 1996 Nov; 46(11):1072-6. PubMed ID: 8955867
[TBL] [Abstract][Full Text] [Related]
12. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice.
Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478
[TBL] [Abstract][Full Text] [Related]
13. Effect of D-002 on the pre-ulcerative phase of carrageenan-induced colonic ulceration in the guinea-pig.
Noa M; Mas R
J Pharm Pharmacol; 1998 May; 50(5):549-53. PubMed ID: 9643449
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Schmidt C; Kosché E; Baumeister B; Vetter H
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
[TBL] [Abstract][Full Text] [Related]
15. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
16. The pre-ulcerative phase of carrageenan-induced colonic ulceration in the guinea-pig.
Marcus SN; Marcus AJ; Marcus R; Ewen SW; Watt J
Int J Exp Pathol; 1992 Aug; 73(4):515-26. PubMed ID: 1356411
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease.
Sykes AP; Brampton C; Klee S; Chander CL; Whelan C; Parsons ME
Inflamm Res; 2000 Jul; 49(7):311-9. PubMed ID: 10959551
[TBL] [Abstract][Full Text] [Related]
18. The comparative prophylactic effects of sulphasalazine, prednisolone and azathioprine in experimental colonic ulceration.
Watt J; Marcus SN; Marcus AJ
J Pharm Pharmacol; 1980 Dec; 32(12):873-4. PubMed ID: 6110761
[No Abstract] [Full Text] [Related]
19. The prophylactic effect of 5-aminosalicylic acid and salazosulphapyridine on degraded-carrageenan-induced colitis in guinea pigs.
Jensen BH; Andersen JO; Poulsen SS; Skov Olsen P; Nørby Rasmussen S; Hansen SH; Hvidberg EF
Scand J Gastroenterol; 1984 May; 19(3):299-303. PubMed ID: 6146186
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental autoimmune encephalomyelitis by sulfasalazine.
Prosiegel M; Neu I; Vogl S; Hoffmann G; Wildfeuer A; Ruhenstroth-Bauer G
Acta Neurol Scand; 1990 Mar; 81(3):237-8. PubMed ID: 1972308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
